WebApr 12, 2024 · Codiak BioSciences has a beta of 3.71, meaning that its share price is 271% more volatile than the S&P 500. Comparatively, Brainstorm Cell Therapeutics has a beta of -0.38, meaning that its share ... Web2 days ago · Analyst Forecast. According to 7 analysts, the average rating for BCLI stock is "Buy." The 12-month stock price forecast is $7.14, which is an increase of 363.64% …
BCLI - Brainstorm Cell Therapeutics Inc Stock quote
WebOct 15, 2024 · NEW YORK, Oct. 15, 2024 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, announced today financial ... WebBrainstorm Cell Therapeutics Inc. Common Stock (BCLI) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets. sharp objects show cast
Brainstorm Cell Therapeutics (BCLI) Stock Price, Quote
WebApr 6, 2024 · Get Brainstorm Cell Therapeutics Inc (BCLI:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. WebCOMMON STOCK PURCHASE WARRANT . brainstorm cell therapeutics inc. Warrant Shares: [_____] Initial Exercise Date: August [____], 2013 . ... The purchase price of one share of Common Stock under this Warrant shall … WebBCLI - Brainstorm Cell Stock Price - Barchart.com Brainstorm Cell (BCLI) Try Excel Alerts Watch Help Go To: Full Chart Realtime quote and/or trades are not sourced from all markets. Fundamentals Market Capitalization, $K 59,563 Shares Outstanding, K 36,542 Annual Sales, $ 0 K Annual Income, $ -24,460 K 60-Month Beta -0.44 Price/Sales N/A sharp objects toolbox talks